Comparable outcomes of patients eligible vs ineligible for SWOG leukemia studies

Patients may be deemed ineligible for a clinical trial for reasons that do not directly impact efficacy or safety. We identified reasons for ineligibility and compared outcomes of ineligible with eligible patients treated on Southwest Oncology Group (SWOG) Leukemia Committee protocols. Patients enro...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Blood
Главные авторы: Statler, Abby, Othus, Megan, Erba, Harry P., Chauncey, Thomas R., Radich, Jerald P., Coutre, Steven, Advani, Anjali, Nand, Sucha, Ravandi, Farhad, Mukherjee, Sudipto, Sekeres, Mikkael A.
Формат: Artigo
Язык:Inglês
Опубликовано: American Society of Hematology 2018
Предметы:
Clinical Trials and Observations
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6014358/
https://ncbi.nlm.nih.gov/pubmed/29618479
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2018-01-826693
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы